HEJDUK, Karel, Michal BURGER, Matyáš KUHN, Kateřina FRÖHLICH, Petra OVESNÁ, Tomáš PAVLÍK and Jiří JARKOVSKÝ. Analytický report databáze VILP: přípravek PERJETA (pertuzumab) (Analytical report of the VILP database: PERJETA (pertuzumab)). Brno: Masarykova univerzita, 2015, 19 pp.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Analytický report databáze VILP: přípravek PERJETA (pertuzumab)
Name (in English) Analytical report of the VILP database: PERJETA (pertuzumab)
Authors HEJDUK, Karel (203 Czech Republic, guarantor, belonging to the institution), Michal BURGER (203 Czech Republic, belonging to the institution), Matyáš KUHN (203 Czech Republic, belonging to the institution), Kateřina FRÖHLICH (203 Czech Republic, belonging to the institution), Petra OVESNÁ (203 Czech Republic, belonging to the institution), Tomáš PAVLÍK (203 Czech Republic, belonging to the institution) and Jiří JARKOVSKÝ (203 Czech Republic, belonging to the institution).
Edition Brno, 19 pp. 2015.
Publisher Masarykova univerzita
Other information
Original language Czech
Type of outcome Research report
Field of Study 30200 3.2 Clinical medicine
Country of publisher Czech Republic
Confidentiality degree is not subject to a state or trade secret
RIV identification code RIV/00216224:14110/15:00086900
Organization unit Faculty of Medicine
Keywords in English breast cancer; registry; targeted therapy; pertuzumab
Changed by Changed by: Mgr. Jakub Gregor, Ph.D., učo 16577. Changed: 4/3/2016 13:40.
Abstract
Tato zpráva sumarizuje data shromážděná z reálné klinické praxe při používání přípravku PERJETA u pacientek s karcinomem prsu
Abstract (in English)
The report summarizes clinical practice data on the use of PERJETA therapy in patients with breast carcinoma
PrintDisplayed: 22/7/2024 23:20